期刊文献+

β-防御素2真核表达载体的构建及其在肝癌细胞Hepa1-6中的稳定表达 被引量:1

Construction of beta-defensin 2 secretory eukaryotic expression vector and identification of stable expression of mBD2 in Hepa1-6 cell
下载PDF
导出
摘要 目的克隆抗菌肽β防御素2(mBD2)基因,构建真核分泌性表达载体,使其在Hepa1-6细胞中稳定表达。方法Trizol试剂提取C57BL/6鼠肾总RNA,RT-PCR扩增mBD2成熟肽基因,Overlap-PCR在成熟肽基因上游加上鼠IgК信号肽基因,克隆至真核表达载体pcDNA3.1(+),PCR、酶切和测序鉴定正确后,脂质体法转染Hepa1-6细胞,G418筛选,RT-PCR和Western印迹法从mRNA和蛋白角度鉴定mBD2分子的表达。结果成功克隆含有信号肽的IgК-mBD2序列,并且构建pcDNA3.1(+)/IgК-mBD2真核分泌性表达载体,实现了mBD2分子在Hepa1-6细胞中稳定表达,RT-PCR从细胞总RNA中扩增得到202bp的IgК-mBD2基因,Western印迹法鉴定细胞培养上清中有mBD2蛋白分子表达。结论成功构建了pcDNA3.1(+)/IgК-mBD2真核分泌性表达载体,转染得到稳定表达mBD2的Hepa1-6细胞株,为进一步研究mBD2的生物学特性及抗肝癌机制奠定细胞学基础。 Objective To clone beta defensin 2 (mBD2) gene from total RNA of mouse kidney,and to construct mBD2 secretary eukaryotic expression vector,then realize its expression in Hepa1-6 cells. Methods Total RNA was isolated from kidney of C57BL/6 mice by Trizol reagent. DNA sequence coding for mature mBD2 was amplified by RT-PCR. To add a murine Igκ signal peptide sequence by overlap-PCR. After successfully T-A clone,Igκ-mBD2 was subcloned into the plasmid pcDNA3.1 (+).The pcDNA3.1 (+) / Igκ-mBD2 was identified by PCR,endonuclease digestion,and sequencing. The Hepa 1-6 cells were transfected with pcDNA3.1(+)/Igκ-mBD2 by Liposome2000 and selected with 400 mg /L G418 for 8 w. Identification of steady expression of mBD2 was confirmed by RT-PCR and Western blot. Results The eukaryotic expression vector-pcDNA3.1 (+)/Igκ-mBD2 was successfully constructed. Stable expressional cell line of Hepa 1-6 was obtained by transfecting pcDNA3.1 (+)/Igκ-mBD2 into Hepa 1-6 by Liposome2000. The steady expression of mBD2 was confirmed by RT-PCR and Western blot. Conclusions The eukaryotic vector of pcDNA3.1 (+) / Igκ-mBD2 is successfully constructed,and mBD2 stable expressional Hepa 1-6 cell line is identified,which is good foundation for further research on biological characteristic and anti-tumor mechanisms of mBD2.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第9期1213-1215,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金资助项目(36071832)
关键词 防御素 天然免疫 肝癌 Overlap-PCR Defensin Natural immunity Liver cancer Overlap-PCR
  • 相关文献

参考文献9

  • 1高新生,林菊生.原发性肝癌基因治疗的研究进展[J].胃肠病学和肝病学杂志,2008,17(12):959-961. 被引量:2
  • 2Ruben HA,Bruno S,Jesus P.Gene therapy of liver cancer[J].Annals Hepatol,2007;6(1):5-14.
  • 3Biragyn A,Ruffini PA,Leifer CA,et al.Toll-like receptor 4 dependent activation of dendritic cells by β-defensin 2[J].Science,2002;298(5595):1025-9.
  • 4Bowdish DM,Davidson DJ,Hancock RE.Immunomodulatory properties of defensins and cathelicidins[J].Curr Top Microbiol Immunol,2006;306:27-66.
  • 5Biragyn A,Surenhu M,Yang D,et al.Mediators of innate immunity that target immature,but not mature,dendritic cells induce antitumou immunity when genetically fused with nonimmunogenic tumor antigens[J].J Immunol,2001;167(11):6644-53.
  • 6王国庆,王永生,王瑞,吴杨,杜小波,徐建容,刁鹏.防御素2融合VE-Cadherin重组质粒的抗血管生成免疫作用[J].四川大学学报(医学版),2006,37(3):344-348. 被引量:3
  • 7Wang YS,Wang GQ,Wen YJ,et al.Immunity against tumor angiogenesis induced by a fusion vaccine with murine β-defensin 2 and mFlk-1[J].Clin Cancer Res,2007;13(22):6779-87.
  • 8刘贵霞,金玉怀,殷长甫,高志云,揣侠,蓝佳明,张永红,李嘉,李伟,王永祥.小鼠β防御素2与柯萨奇病毒B3 VP1融合基因疫苗的构建和免疫效果研究[J].中国免疫学杂志,2009,25(7):647-650. 被引量:3
  • 9Ma XT,Xu B,An LL,et al.Vaccine with β-defensin-2 transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemine responses[J].Cancer Res,2006;66(2):1169-76.

二级参考文献12

共引文献5

同被引文献11

  • 1王淑为,马小彤,徐玢,杨宾霞,段永娟,林永敏.小鼠β-防御素2与白介素18肿瘤疫苗的协同抗白血病作用研究[J].现代免疫学,2009,29(1):40-44. 被引量:3
  • 2王国庆,王永生,王瑞,吴杨,杜小波,徐建容,刁鹏.防御素2融合VE-Cadherin重组质粒的抗血管生成免疫作用[J].四川大学学报(医学版),2006,37(3):344-348. 被引量:3
  • 3Biragyn A, Surenhu M, Yang D, et al. Mediators of innate immunity that target immature, but not mature, dendritic ceils induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens [J]. J Immunol, 2001, 167(11) : 6644 -6653.
  • 4Wang Y S, Wang G Q, Wen Y J, et al. Immunity against tumor anglogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1 [ J]. Clin Cancer Res, 2007, 13 (22 Pt 1 ) : 6779 - 6787.
  • 5Ma X T, Xu B, An L L, et al. Vaccine with beta-defensin 2-transduced leukemic ceils activates innate and adaptive immunity to elicit potent antileukemia responses [ J ]. Cancer Res, 2006, 66 (2) : 1169 - 1176.
  • 6Giblin A V, Thomas J M. Incidence, mortality and survival in cutaneous melanoma [ J]. J Plast Reconstr Aesthet Surg, 2007, 60 (1): 32 - 40.
  • 7Lens M. The role of vaccine therapy in the treatment of melanoma[ J ]. Expert Opin Biol Ther, 2008, 8(3) : 315 -323.
  • 8Huo L, Yao H, Wang X, et al. Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL6/J mice [J]. PLoS One, 2010, 5(9) : e12705.
  • 9Kochenderfer J N, Gress R E. A comparison and critical analysis of preclinical anticancer vaccination strategies [ J ]. Exp Biol Med ( Maywood), 2007, 23(9) : 1130-1141.
  • 10Biragyn A, Ruffini P A, Leifer C A, et al. Toll-like receptor 4-dependent activation of dendritic ceils by beta-defensin 2 [ J ]. Science, 2002, 298(5595) : 1025 - 1029.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部